Plus: Gloria Steinem, Feminist Icon and Reproductive Rights Advocate, Dies at 92
͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
|
|
|
|
| Weekly News Roundup: Cancer Breakthroughs, FDA Recall, and CKM Health |
| From major clinical milestones in oncology to public health topics to one news editor’s first-hand experience living with PMOS, our newsroom shared several important stories this week. Here is your quick breakdown. |
In oncology news, the FDA approved Rasonque, a breakthrough targeted therapy for metastatic pancreatic cancer. In clinical trials, the drug more than doubled median survival rates compared to chemotherapy, offering a significant step forward for one of the most aggressive forms of cancer.
On the public health front, the FDA announced recalls of specific IV saline and nutrient fluids due to potential contamination with hazardous particles like fiberglass and stainless steel, urging healthcare professionals to check lot numbers immediately.
In other health news, a new study reveals that nearly 80% of adults in their 20s show early signs of cardiovascular-kidney-metabolic (CKM) syndrome, highlighting the need to address high blood pressure and blood sugar early in life.
Meanwhile, Mandy French, a news editor on our team, shares her personal five-year journey to a diagnosis, reflecting on how the official renaming of PCOS to PMOS (polyendocrine metabolic ovarian syndrome) brings renewed hope for faster, clearer care.
Which story got your attention? Let us know your thoughts. |
 |
| Angela Chao, MA |
| Head of Global News |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Until next time, |
 |
Take care of yourself, and we'll
see you again soon! |
|
|
View in browser
Did a friend send you this email? Subscribe here.
To see all newsletters, click here.
Privacy | Update Preferences or Unsubscribe
We may feature your messages to our inbox within our content. Please do not provide any personal identifiable information. Replies may be edited for length and clarity. For more, see our Privacy Policy.
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional.
Every product we recommend has gone through either Healthline's or Optum Now's vetting processes. If you buy through links on this page, we may receive a small commission or other tangible benefit. Healthline has sole editorial control over this newsletter. Potential uses for the products listed here are not health claims made by the manufacturers. Healthline and Optum Now are owned by RVO Health.
We may feature your messages to our inbox within our content. Please do not provide any personal identifiable information. Replies may be edited for length and clarity. For more, see our Privacy Policy.
Our website services, content, and products are for informational purposes only. Healthline does not provide medical advice, diagnosis, or treatment and should not be used as a substitute for medical advice from a healthcare professional. Healthline encourages you to make any treatment decisions with your healthcare professional.
Every product we recommend has gone through either Healthline’s or Optum Now’s vetting processes. If you buy through links on this page, we may receive a small commission or other tangible benefit. Healthline has sole editorial control over this newsletter. Potential uses for the products listed here are not health claims made by the manufacturers. Healthline and Optum Now are owned by RVO Health.
© 2026 RVO Health
1101 Red Ventures Drive
Fort Mill, SC 29707 |
|
If you believe this has been sent to you in error, please safely unsubscribe.
No comments:
Post a Comment